Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)-Reference-Cited by-同舟云学术

Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)

Published:2013-12 Issue:1 Volume:32 Page:124-130
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Bettinger Julie A.,Scheifele David W.,Halperin Scott A.,Vaudry Wendy,Findlow Jamie,Borrow Ray,Medini Duccio,Tsang Raymond

Funder

Sanofi-Pasteur

Novartis Vaccines & Diagnostics

Michael Smith Foundation for Health Research

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference31 articles.

1. Update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS);Can Commun Dis Rep,2009

2. The disease burden of invasive meningococcal serogroup B disease in Canada;Bettinger;Pediatr Infect Dis J,2013

3. Cell adhesion molecules;Edelman;Science,1983

5. Reverse vaccinology;Rappuoli;Curr Opin Microbiol,2000

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-genome sequencing of Neisseria meningitidis collected in Chile from pediatric patients during 2016–2019 and coverage vaccine prediction;Vaccine;2024-12

2. An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infants;Archives of Disease in Childhood;2024-07-08

3. Meningococcal Vaccines Directed at Capsular Group B;Plotkin's Vaccines;2023

4. Meningococcal disease in North America: Updates from the Global Meningococcal Initiative;Journal of Infection;2022-12

5. Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines;mSphere;2022-10-26